Erdafitinib

CHEBI:CHEBI_751463

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2123145
generic_name
Erdafitinib
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
nui
N0000194026
pharm_class_moa
Fibroblast Growth Factor Receptor Inhibitors [MoA]
pharm_class
Fibroblast Growth Factor Receptor Inhibitors [MoA]
dosage_form
POWDER
active_ingredient_strength
1 kg/kg
marketing_start_date
20231128
package_marketing_start_date
04-DEC-19
pharm_class_epc
Kinase Inhibitor [EPC]
labeler_name
Cilag AG
manufacturer_name
Janssen Products LP
product_ndc
12502-6848
spl_id
f2b3d2e7-03ba-54b1-e053-2995a90a3485
active_ingredient_name
ERDAFITINIB
package_ndc
12502-6848-9
package_description
2.45 kg in 1 DRUM (12502-6848-9)
brand_name
BALVERSA
brand_name_base
BALVERSA
application_number
NDA212018
unii
890E37NHMV
spl_set_id
2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class